Protein Found to Drive Breast Cancer Drug Resistance
Researchers have identified a protein that helps triple-negative breast cancer cells repair DNA damage caused by chemotherapy.
Updated on Oct. 21, 2026 in Cancer
Live Poll
Do you trust that recent scientific discoveries in cancer research will soon improve your treatment options?
Roswell Park Comprehensive Cancer Center researchers have discovered that the protein MPP8 acts as a key driver of chemotherapy resistance in triple-negative breast cancer. By suppressing this protein, scientists were able to increase the vulnerability of cancer cells to standard treatments.
Why it matters
Understanding the role of MPP8 is critical because about half of triple-negative breast cancer patients face treatment resistance. Identifying these expression levels could allow doctors to better match patients with effective therapies.
A study in the journal Advanced Science reports that elevated MPP8 levels assist cancer cells in repairing double-strand DNA breaks. Approximately 50% of all triple-negative breast cancer patients exhibit tumors that fail to respond to standard chemotherapy.
The players
Roswell Park Comprehensive Cancer Center
Founded in 1898 in Buffalo, New York, this facility employs over 4,000 staff and focuses on advanced oncology research.
Dr. Jia Fang
A researcher known for his 2010 work establishing that MPP8 contributes to tumor gene silencing and cancer metastasis.
National Cancer Institute
This federal agency is part of the U.S. National Institutes of Health and provided financial support for the study.
The details
The study reveals that MPP8 utilizes the dominant DNA double-strand break repair pathway in human cells to negate the effects of chemotherapy. By experimentally suppressing the expression of this protein, researchers successfully resensitized resistant breast cancer cells to treatment.
Timeline
2010: Dr. Jia Fang published early findings on the role of MPP8 in silencing tumor-suppressing genes.
October 2026: Research findings were officially reported in the journal Advanced Science.
The Big Picture
This discovery marks a significant shift in cancer research by identifying a specific protein-based mechanism for drug resistance. It builds upon the broader institutional research efforts supported by the National Cancer Institute to improve outcomes for treatment-resistant malignancies.
This research provides a new potential target for future diagnostic tests that could help identify which patients might benefit from alternative treatment plans. Patients currently undergoing chemotherapy may eventually see new therapies that specifically account for MPP8 expression levels.
The takeaway
This finding highlights that molecular biology can hold the key to overcoming long-standing challenges in chemotherapy efficacy. Researchers suggest that future clinical practices could rely on screening for these protein levels to personalize cancer care strategies.
Further reading
For more information on current developments, visit the Cancer research section.
Source note: This article includes information reported by Buffalo News.
Live Poll
Do you trust that recent scientific discoveries in cancer research will soon improve your treatment options?
